Morning Market Gainers

AVEO Pharmaceuticals, Inc. AVEO shares jumped 55.21 percent to $2.48. On Wednesday, the company reported final results from its TIVO-1 extension study. Ampio Pharmaceuticals Inc AMPE shares climbed 33 percent to $2.70 after the company reported positive results of its OptimEyes trial for DME. CTPartners Executive Search Inc CTP shares surged 29.38 percent to $4.00 after the company agreed to exclusive negotiations to be acquired by DHR International. IntelliPharmaCeutics Intl Inc (USA) IPCI shares rose 25.55 percent to $3.40. The company will accelerate its Rexista(TM) Oxycodone XR development program on the basis of positive feedback from the United States Food and Drug Administration. Calithera Biosciences Inc CALA shares gained 24.44 percent to $13.50 after the company issued positive initial Phase I safety data for CB-839 in patients with acute leukemia. Youku Tudou Inc (ADR) YOKU shares rose 16.38 percent to $26.79. Youku reported a Q1 loss of $0.40 per share on non-GAAP sales of $170.4 million. Brean Capital maintained Buy rating on Youku Tudou and raised the price target from $20 to $26. bluebird bio Inc BLUE shares jumped 10.34 percent to $182.84. bluebird bio will present LentiGlobin clinical data on June 13, 2015 at the 20th Congress of European Hematology Association Kirkland's, Inc. KIRK rose 10.06 percent to $27.67 after the company reported stronger-than-expected earnings for the fiscal first quarter on Thursday. Best Buy Co Inc BBY shares climbed 4.80 percent to $35.40 after the company reported stronger-than-expected results for the first quarter on Thursday. salesforce.com, inc. CRM shares gained 4.76 percent to $73.50 after the company reported better-than-expected earnings for the first quarter and lifted its sales outlook for the full year. Donaldson Company, Inc. DCI shares gained 2.69 percent to $36.60 after the company reported better-than-expected earnings for the fiscal third quarter. Omnicare, Inc. OCR shares rose 1.22 percent to $95.78 session after CVS Health Corp CVS announced its plans to buy Omnicare for about $12.7 billion.